Stocks and Investing Stocks and Investing
Tue, August 25, 2020
Mon, August 24, 2020
Fri, August 21, 2020
Thu, August 20, 2020
Wed, August 19, 2020
Tue, August 18, 2020
Mon, August 17, 2020

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $175 on, Aug 17th, 2020


Published on 2024-10-27 12:18:26 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $200 to $175 on, Aug 17th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Geoff Meacham of "B of A Securities" Reiterated at Strong Buy with Increased Target to $63 on, Monday, July 13th, 2020

Similar Stocks and Investing Articles